RNA polymerase III transcription in cancer: The BRF2 connection

Molecular Cancer

Volumn 10, Issue , 2011, Pages

  Cabarcas, Stephanie ^a   Schramm, Laura ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b ST JOHN'S UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA DIRECTED RNA POLYMERASE III; TRANSCRIPTION FACTOR IIIB; BRF2 PROTEIN, HUMAN;

BRF2 GENE; CANCER RISK; DATA BASE; GENETIC TRANSCRIPTION; HIGH RISK PATIENT; HUMAN; KIDNEY CANCER; LEUKEMIA; LUNG CANCER; LYMPHOMA; MELANOMA; NEOPLASM; NONHUMAN; ONCOGENE; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; STOMACH CANCER; TUMOR SUPPRESSOR GENE; ANIMAL; BIOLOGICAL MODEL; ENZYMOLOGY; GENETICS; GENOMICS; METABOLISM;

ANIMALS; GENOMICS; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; RNA POLYMERASE III; TRANSCRIPTION FACTOR TFIIIB; TRANSCRIPTION, GENETIC;

EID: 79955035405     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-10-47     Document Type: Review

References (61)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009, 59(4):225-49. 10.3322/caac.20006, 19474385.
2. Schramm L, Hernandez N. Recruitment of RNA polymerase III to its target promoters. Genes Dev 2002, 16(20):2593-620. 10.1101/gad.1018902, 12381659.
3. Huang Y, Maraia RJ. Comparison of the RNA polymerase III transcription machinery in Schizosaccharomyces pombe, Saccharomyces cerevisiae and human. Nucleic Acids Res 2001, 29(13):2675-90. 10.1093/nar/29.13.2675, 55761, 11433012.
4. Geiduschek EP, Kassavetis GA. The RNA polymerase III transcription apparatus. J Mol Biol 2001, 310(1):1-26. 10.1006/jmbi.2001.4732, 11419933.
5. Dieci G, Fiorino G, Castelnuovo M, Teichmann M, Pagano A. The expanding RNA polymerase III transcriptome. Trends Genet 2007, 23(12):614-22. 10.1016/j.tig.2007.09.001, 17977614.
6. Saxena A, Ma B, Schramm L, Hernandez N. Structure-function analysis of the human TFIIB-related factor II protein reveals an essential role for the C-terminal domain in RNA polymerase III transcription. Mol Cell Biol 2005, 25(21):9406-18. 10.1128/MCB.25.21.9406-9418.2005, 1265830, 16227591.
7. Wang HD, Yuh CH, Dang CV, Johnson DL. The hepatitis B virus X protein increases the cellular level of TATA-binding protein, which mediates transactivation of RNA polymerase III genes. Mol Cell Biol 1995, 15(12):6720-8. 230925, 8524237.
8. White RJ, Stott D, Rigby PW. Regulation of RNA polymerase III transcription in response to Simian virus 40 transformation. Embo J 1990, 9(11):3713-21. 552127, 2170119.
9. Gottesfeld JM, Johnson DL, Nyborg JK. Transcriptional activation of RNA polymerase III-dependent genes by the human T-cell leukemia virus type 1 tax protein. Mol Cell Biol 1996, 16(4):1777-85. 231164, 8657153.
10. Larminie CG, Sutcliffe JE, Tosh K, Winter AG, Felton-Edkins ZA, White RJ. Activation of RNA polymerase III transcription in cells transformed by simian virus 40. Mol Cell Biol 1999, 19(7):4927-34. 84300, 10373542.
11. Felton-Edkins ZA, White RJ. Multiple mechanisms contribute to the activation of RNA polymerase III transcription in cells transformed by papovaviruses. J Biol Chem 2002, 277(50):48182-91. 10.1074/jbc.M201333200, 12370195.
12. Chen W, Bocker W, Brosius J, Tiedge H. Expression of neural BC200 RNA in human tumours. J Pathol 1997, 183(3):345-51. 10.1002/(SICI)1096-9896(199711)183:3<345::AID-PATH930>3.0.CO;2-8, 9422992.
13. Winter AG, Sourvinos G, Allison SJ, Tosh K, Scott PH, Spandidos DA, White RJ. RNA polymerase III transcription factor TFIIIC2 is overexpressed in ovarian tumors. Proc Natl Acad Sci USA 2000, 97(23):12619-24. 10.1073/pnas.230224097, 18813, 11058163.
14. Pavon-Eternod M, Gomes S, Geslain R, Dai Q, Rosner MR, Pan T. tRNA over-expression in breast cancer and functional consequences. Nucleic Acids Res 2009, 37(21):7268-80. 10.1093/nar/gkp787, 2790902, 19783824.
15. Marshall L, White RJ. Non-coding RNA production by RNA polymerase III is implicated in cancer. Nat Rev Cancer 2008, 8(12):911-4. 10.1038/nrc2539, 18987635.
16. Marshall L, Kenneth NS, White RJ. Elevated tRNA(iMet) synthesis can drive cell proliferation and oncogenic transformation. Cell 2008, 133(1):78-89. 10.1016/j.cell.2008.02.035, 18394991.
17. Johnson SA, Dubeau L, Kawalek M, Dervan A, Schonthal AH, Dang CV, Johnson DL. Increased expression of TATA-binding protein, the central transcription factor, can contribute to oncogenesis. Mol Cell Biol 2003, 23(9):3043-51. 10.1128/MCB.23.9.3043-3051.2003, 153209, 12697807.
18. Melchor L, Garcia MJ, Honrado E, Pole JC, Alvarez S, Edwards PA, Caldas C, Brenton JD, Benitez J. Genomic analysis of the 8p11-12 amplicon in familial breast cancer. Int J Cancer 2007, 120(3):714-7. 10.1002/ijc.22354, 17096335.
19. Garcia MJ, Pole JC, Chin SF, Teschendorff A, Naderi A, Ozdag H, Vias M, Kranjac T, Subkhankulova T, Paish C, Ellis I, Brenton JD, Edwards PA, Caldas C. A 1 Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenes. Oncogene 2005, 24(33):5235-45. 10.1038/sj.onc.1208741, 15897872.
20. Lockwood WW, Chari R, Coe BP, Thu KL, Garnis C, Malloff CA, Campbell J, Williams AC, Hwang D, Zhu CQ, Buys TP, Yee J, English JC, Macaulay C, Tsao MS, Gazdar AF, Minna JD, Lam S, Lam WL. Integrative Genomic Analyses Identify BRF2 as a Novel Lineage-Specific Oncogene in Lung Squamous Cell Carcinoma. PLoS Med 2010, 7(7):e1000315. 10.1371/journal.pmed.1000315, 2910599, 20668658.
21. Scott PH, Cairns CA, Sutcliffe JE, Alzuherri HM, McLees A, Winter AG, White RJ. Regulation of RNA polymerase III transcription during cell cycle entry. J Biol Chem 2001, 276(2):1005-14. 10.1074/jbc.M005417200, 11024049.
22. Schwartz LB, Sklar VE, Jaehning JA, Weinmann R, Roeder RG. Isolation and partial characterization of the multiple forms of deoxyribonucleic acid-dependent ribonucleic acid polymerase in the mouse myeloma, MOPC 315. J Biol Chem 1974, 249(18):5889-97.
23. Johnson SA, Dubeau L, Johnson DL. Enhanced RNA polymerase III-dependent transcription is required for oncogenic transformation. J Biol Chem 2008, 283(28):19184-91. 10.1074/jbc.M802872200, 2443659, 18456653.
24. Johnson SS, Zhang C, Fromm J, Willis IM, Johnson DL. Mammalian Maf1 is a negative regulator of transcription by all three nuclear RNA polymerases. Mol Cell 2007, 26(3):367-79. 10.1016/j.molcel.2007.03.021, 17499043.
25. Reina JH, Azzouz TN, Hernandez N. Maf1, a New Player in the Regulation of Human RNA Polymerase III Transcription. PLoS ONE 2006, 1:e134. 10.1371/journal.pone.0000134, 1762419, 17205138.
26. Rollins J, Veras I, Cabarcas S, Willis I, Schramm L. Human Maf1 negatively regulates RNA polymerase III transcription via the TFIIB family members Brf1 and Brf2. Int J Biol Sci 2007, 3(5):292-302. 1865091, 17505538.
27. Goodfellow SJ, Graham EL, Kantidakis T, Marshall L, Coppins BA, Oficjalska-Pham D, Gerard M, Lefebvre O, White RJ. Regulation of RNA Polymerase III Transcription by Maf1 in Mammalian Cells. J Mol Biol 2008,
28. Jacob J, Cabarcas S, Veras I, Zaveri N, Schramm L. The green tea component EGCG inhibits RNA polymerase III transcription. Biochem Biophys Res Commun 2007, 360(4):778-83. 10.1016/j.bbrc.2007.06.114, 3010276, 17624304.
29. Johnston IM, Allison SJ, Morton JP, Schramm L, Scott PH, White RJ. CK2 forms a stable complex with TFIIIB and activates RNA polymerase III transcription in human cells. Mol Cell Biol 2002, 22(11):3757-68. 10.1128/MCB.22.11.3757-3768.2002, 133823, 11997511.
30. Felton-Edkins ZA, Kenneth NS, Brown TR, Daly NL, Gomez-Roman N, Grandori C, Eisenman RN, White RJ. Direct regulation of RNA polymerase III transcription by RB, p53 and c-Myc. Cell Cycle 2003, 2(3):181-4.
31. Marshall L, White RJ. Non-coding RNA production by RNA polymerase III is implicated in cancer. Nat Rev Cancer 2008,
32. Mauger E, Scott PH. Mitogenic stimulation of transcription by RNA polymerase III. Biochem Soc Trans 2004, 32(Pt 6):976-7.
33. White RJ. RNA polymerase III transcription--a battleground for tumour suppressors and oncogenes. Eur J Cancer 2004, 40(1):21-7. 10.1016/j.ejca.2003.09.027, 14687785.
34. White RJ. RNA polymerase III transcription and cancer. Oncogene 2004, 23(18):3208-16. 10.1038/sj.onc.1207547, 15094770.
35. White RJ. RNA polymerases I and III, growth control and cancer. Nat Rev Mol Cell Biol 2005, 6(1):69-78. 10.1038/nrm1551, 15688068.
36. White RJ. RNA polymerases I and III, non-coding RNAs and cancer. Trends Genet 2008,
37. Morton JP, Kantidakis T, White RJ. RNA polymerase III transcription is repressed in response to the tumour suppressor ARF. Nucleic Acids Res 2007, 35(9):3046-52. 10.1093/nar/gkm208, 1888803, 17439968.
38. Chu WM, Wang Z, Roeder RG, Schmid CW. RNA polymerase III transcription repressed by Rb through its interactions with TFIIIB and TFIIIC2. J Biol Chem 1997, 272(23):14755-61. 10.1074/jbc.272.23.14755, 9169441.
39. Cairns CA, White RJ. p53 is a general repressor of RNA polymerase III transcription. Embo J 1998, 17(11):3112-23. 10.1093/emboj/17.11.3112, 1170650, 9606193.
40. Chesnokov I, Chu WM, Botchan MR, Schmid CW. p53 inhibits RNA polymerase III-directed transcription in a promoter-dependent manner. Mol Cell Biol 1996, 16(12):7084-8. 231711, 8943363.
41. Crighton D, Woiwode A, Zhang C, Mandavia N, Morton JP, Warnock LJ, Milner J, White RJ, Johnson DL. p53 represses RNA polymerase III transcription by targeting TBP and inhibiting promoter occupancy by TFIIIB. Embo J 2003, 22(11):2810-20. 10.1093/emboj/cdg265, 156762, 12773395.
42. Stein T, Crighton D, Boyle JM, Varley JM, White RJ. RNA polymerase III transcription can be derepressed by oncogenes or mutations that compromise p53 function in tumours and Li-Fraumeni syndrome. Oncogene 2002, 21(19):2961-70. 10.1038/sj.onc.1205372, 12082526.
43. Stein T, Crighton D, Warnock LJ, Milner J, White RJ. Several regions of p53 are involved in repression of RNA polymerase III transcription. Oncogene 2002, 21(36):5540-7. 10.1038/sj.onc.1205739, 12165852.
44. Veras I, Rosen EM, Schramm L. Inhibition of RNA Polymerase III Transcription by BRCA1. Journal of Molecular Biology 2009, 387(3):523-531. 10.1016/j.jmb.2009.02.008, 19361418.
45. Burkhart DL, Sage J. Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nat Rev Cancer 2008, 8(9):671-82. 10.1038/nrc2399, 18650841.
46. Hirsch HA, Gu L, Henry RW. The retinoblastoma tumor suppressor protein targets distinct general transcription factors to regulate RNA polymerase III gene expression. Mol Cell Biol 2000, 20(24):9182-91. 10.1128/MCB.20.24.9182-9191.2000, 102176, 11094070.
47. Larminie CG, Cairns CA, Mital R, Martin K, Kouzarides T, Jackson SP, White RJ. Mechanistic analysis of RNA polymerase III regulation by the retinoblastoma protein. Embo J 1997, 16(8):2061-71. 10.1093/emboj/16.8.2061, 1169809, 9155032.
48. Sutcliffe JE, Brown TR, Allison SJ, Scott PH, White RJ. Retinoblastoma protein disrupts interactions required for RNA polymerase III transcription. Mol Cell Biol 2000, 20(24):9192-202. 10.1128/MCB.20.24.9192-9202.2000, 102177, 11094071.
49. White RJ, Trouche D, Martin K, Jackson SP, Kouzarides T. Repression of RNA polymerase III transcription by the retinoblastoma protein. Nature 1996, 382(6586):88-90. 10.1038/382088a0, 8657311.
50. Kruse JP, Gu W. Modes of p53 regulation. Cell 2009, 137(4):609-22. 10.1016/j.cell.2009.04.050, 19450511.
51. Gridasova AA, Henry RW. The p53 Tumor Suppressor Protein Represses Human snRNA Gene Transcription by RNA Polymerases II and III Independently of Sequence-Specific DNA Binding. Mol Cell Biol 2005, 25(8):3247-3260. 10.1128/MCB.25.8.3247-3260.2005, 1069601, 15798209.
52. Billack B, Monteiro AN. BRCA1 in breast and ovarian cancer predisposition. Cancer Lett 2005, 227(1):1-7. 10.1016/j.canlet.2004.11.006, 16051027.
53. Deng CX. BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution. Nucleic Acids Res 2006, 34(5):1416-26. 10.1093/nar/gkl010, 1390683, 16522651.
54. Cabarcas S, Jacob J, Veras I, Schramm L. Differential expression of the TFIIIB subunits Brf1 and Brf2 in cancer cells. BMC Mol Biol 2008, 9:74. 10.1186/1471-2199-9-74, 2533013, 18700021.
55. Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Varambally R, Yu J, Briggs BB, Barrette TR, Anstet MJ, Kincead-Beal C, Kulkarni P, Varambally S, Ghosh D, Chinnaiyan AM. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia 2007, 9(2):166-80. 10.1593/neo.07112, 1813932, 17356713.
56. Tomlinson GE, Chen TT, Stastny VA, Virmani AK, Spillman MA, Tonk V, Blum JL, Schneider NR, Wistuba II, Shay JW, Minna JD, Gazdar AF. Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier. Cancer Res 1998, 58(15):3237-42.
57. Hammond-Thelin LA, Thomas MB, Iwasaki M, Abbruzzese JL, Lassere Y, Meyers CA, Hoff P, de Bono J, Norris J, Matsushita H, Mita A, Rowinsky EK. Phase I and pharmacokinetic study of 3'-C-ethynylcytidine (TAS-106), an inhibitor of RNA polymerase I, II and III, in patients with advanced solid malignancies. Invest New Drugs 2010,
58. Talantov D, Mazumder A, Yu JX, Briggs T, Jiang Y, Backus J, Atkins D, Wang Y. Novel genes associated with malignant melanoma but not benign melanocytic lesions. Clin Cancer Res 2005, 11(20):7234-42. 10.1158/1078-0432.CCR-05-0683, 16243793.
59. Gumz ML, Zou H, Kreinest PA, Childs AC, Belmonte LS, LeGrand SN, Wu KJ, Luxon BA, Sinha M, Parker AS, Sun LZ, Ahlquist DA, Wood CG, Copland JA. Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma. Clin Cancer Res 2007, 13(16):4740-9. 10.1158/1078-0432.CCR-07-0143, 17699851.
60. D'Errico M, de Rinaldis E, Blasi MF, Viti V, Falchetti M, Calcagnile A, Sera F, Saieva C, Ottini L, Palli D, Palombo F, Giuliani A, Dogliotti E. Genome-wide expression profile of sporadic gastric cancers with microsatellite instability. Eur J Cancer 2009, 45(3):461-9. 10.1016/j.ejca.2008.10.032, 19775672.
61. Kickhoefer VA, Searles RP, Kedersha NL, Garber ME, Johnson DL, Rome LH. Vault ribonucleoprotein particles from rat and bullfrog contain a related small RNA that is transcribed by RNA polymerase III. J Biol Chem 1993, 268(11):7868-73.